We combined our GFAP.tTA/tetO.IKK2-CA [25,29,34] mouse model with the well-characterized APP23 model of AD to investigate how IKK/NF-κB-driven neuroinflammation affects the pathogenesis of AD. Here, GFAP is linked to Alzheimer disease.